Accountable care organizations (ACOs) are still a new creature in the world of managed care, and not all are alike. As the authors of a new comparative analysis in The American Journal of Managed Care outline, Medicare contracts dominate the ACO landscape, with only half of these entities having a contract with a private payer.
AJMC Takes an Early Glimpse Into ACO Contracts
FOR IMMEDIATE RELEASEDecember 22, 2014
PLAINSBORO, N.J.—Less than a decade after healthcare’s first experiments with “accountable care organizations,” the ACO has gained a foothold through its inclusion in the Affordable Care Act (ACA). Yet not all ACOs are created equal, as the authors of a new article in The American Journal of Managed Care showed in a comparative analysis published this month. A full copy of the analysis can be found here.
Led by Valerie A. Lewis, PhD, this analysis used data from the National Survey of Accountable Care Organizations, and included ACOs that had been established by August 2012—and had information that was publicly available. “Our data provide the first comprehensive, systematic picture of the commercial ACO contract landscape,” the authors note. “Our results illuminate how commercial ACO contracts compare with public ACO contracts, as well as what types of provider organizations are pursuing each type of contract.”
Among the findings:
Commercial contracts with more complex risk features and upfront payments are still less common, but where they exist, these arrangements are more sophisticated and collaborative. Private ACO contracts were more likely to have these features (compared with public contracts):
Organizations with private ACO contracts were more likely to have experience with pay-for-performance plans, such as patient centered medical homes, public reporting, and risk-based contracting. These entities also employed more full-time physicians.
About the Journals
The American Journal of Managed Care, now in its 20th year of publication, is the leading peer-reviewed journal dedicated to issues in managed care. The American Journal of Pharmacy Benefits, provides pharmacy and formulary decision-makers with information to improve the efficiency and health outcomes in managing pharmaceutical care. In December 2013, AJMC introduced The American Journal of Accountable Care, which publishes research and commentary devoted to understanding changes to the healthcare system due to the 2010 Affordable Care Act. AJMC’s news publications, the Evidence-Based series, bring together stakeholder views from payers, providers, policymakers and pharmaceutical leaders in oncology and diabetes management. To order reprints of articles appearing in AJMC publications, please call (609) 716-7777, x 131.
CONTACT: Mary Caffrey (609) 716-7777 x 144
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen